Top compounds associated with response to NUAK1


Feature Type Standardized
Nominal ANOVA
mRNA neratinib CTRPv2 pan-cancer AAC -0.025 0.5
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.024 0.5
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.024 0.5
mRNA MS-275 CTRPv2 pan-cancer AAC -0.022 0.5
mRNA avrainvillamide CTRPv2 pan-cancer AAC 0.028 0.5
mRNA AZD0530 CCLE pan-cancer AAC 0.04 0.5
mRNA BRD-K92856060 CTRPv2 pan-cancer AAC -0.025 0.5
mRNA Cetuximab GDSC1000 pan-cancer AAC -0.024 0.5
mRNA GDC-0449 FIMM pan-cancer AAC 0.14 0.5
mRNA MLN2480 CTRPv2 pan-cancer AAC 0.036 0.5
Download CSV